Skip to main content

Find Clinical Trials

Home
Conditions
Non-Hematologic Malignancy

Clinical trial condition

Non-Hematologic Malignancy

Explore clinical trials studying Non-Hematologic Malignancy. Study availability and eligibility vary by location and protocol.

3 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Non-Hematologic Malignancy trial results

Completed

Open-label Study of Surufatinib in Japanese Patients

NCT05077384

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +4 more
Locations: Kyushu University Hospital Fukuoka, Japan

Fukuoka Sanno Hospital Fukuoka, Japan

Kagawa University Hospital Kagawa, Japan

National Cancer Centre Hospital East Kashiwa-shi, Japan

View Trial Details

Completed

Guardant360® Test-Related Clinical Outcomes in Patients Who Share Medical Records

NCT03625557

Conditions: Non-Hematologic Malignancy
Locations: Guardant Health Redwood City, California, United States

View Trial Details

Completed

A Safety, Tolerability, and Pharmacokinetics Study of MLN0128 as a Single Agent and in Combination With Paclitaxel in Adults With Advanced Nonhematologic Malignancies

NCT02412722

Conditions: Non-Hematologic Malignancy
Locations: Scottsdale, Arizona, United States

Sarasota, Florida, United States

Oklahoma City, Oklahoma, United States

Germantown, Tennessee, United States

View Trial Details